Dapagliflozin 5 mg
Sponsors
AstraZeneca, Beni-Suef University
Conditions
PCOType 1 Diabetes MellitusType 2 Diabetes Mellitus
Phase 3
The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM
CompletedNCT02582814
Start: 2015-10-26End: 2017-06-15Updated: 2019-04-12
Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/Saxagliptin
TerminatedNCT03608358
Start: 2019-02-27End: 2020-08-04Updated: 2022-05-31
Dapagliflozin Versus Metformin and Their Combination in Polycystic Ovary Syndrome
CompletedNCT05601336
Start: 2025-05-15End: 2026-05-30Updated: 2026-10-15